{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:10:56Z","timestamp":1792627856945,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004938","name":"Deutsches Primatenzentrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1039"],"award-info":[{"award-number":["SFB1039"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.xpro.2021.100818","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T01:23:33Z","timestamp":1630027413000},"page":"100818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines"],"prefix":"10.1016","volume":"2","author":[{"given":"Madeleine","family":"Eichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5302-2068","authenticated-orcid":false,"given":"Ebru","family":"Aksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Pfeilschifter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Imre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2021.100818_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xpro.2021.100818_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11626-012-9573-1","article-title":"Doxorubicin-treated H9c2 cells: caution with luminescent ATP and Hoechst 33258 assays","volume":"49","author":"Calvert","year":"2013","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.xpro.2021.100818_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/pathogens8040259","article-title":"Entry of scotophilus bat coronavirus-512 and severe acute respiratory syndrome coronavirus in human and multiple animal cells","volume":"8","author":"Chen","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.xpro.2021.100818_bib4","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1128\/JVI.01711-08","article-title":"Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles","volume":"83","author":"Cosset","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xpro.2021.100818_bib5","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent cell line expressing human factor VIII- related antigen established by hybridization","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.xpro.2021.100818_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jmv.20449","article-title":"Replication of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line","volume":"77","author":"Freymuth","year":"2005","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.xpro.2021.100818_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2021.100818_bib8","doi-asserted-by":"crossref","first-page":"102266","DOI":"10.1016\/j.isci.2021.102266","article-title":"The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection","volume":"24","author":"Imre","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xpro.2021.100818_bib9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/v12121457","article-title":"Monitoring viral entry in real-time using a luciferase recombinant vesicular stomatitis virus producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV glycoproteins","volume":"12","author":"Lay Mendoza","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.xpro.2021.100818_bib10","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.21769\/BioProtoc.2035","article-title":"Murine leukemia virus (MLV)-based coronavirus spike-pseudotyped particle production and infection","volume":"6","author":"Millet","year":"2016","journal-title":"Bio Protoc."},{"key":"10.1016\/j.xpro.2021.100818_bib11","article-title":"Production of pseudotyped particles to study highly pathogenic coronaviruses in a biosafety level 2 setting","volume":"145","author":"Millet","year":"2019","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.xpro.2021.100818_bib12","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fmicb.2016.01765","article-title":"Ebola VP40 in exosomes can cause immune cell dysfunction","volume":"7","author":"Pleet","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xpro.2021.100818_bib13","doi-asserted-by":"crossref","first-page":"100133","DOI":"10.1016\/j.xpro.2020.100133","article-title":"A protocol for studying HIV-1 envelope glycoprotein function","volume":"1","author":"Ratnapriya","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xpro.2021.100818_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2021.100818_bib15","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.3390\/ma13194270","article-title":"Carbon nanotubes interference with luminescence-based assays","volume":"13","author":"Szyma\u0144ski","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.xpro.2021.100818_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1750-2659.2007.00016.x","article-title":"A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies","volume":"1","author":"Temperton","year":"2007","journal-title":"Influenza Other Respir. Viruses"}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166721005244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166721005244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:51:28Z","timestamp":1778917888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166721005244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666166721005244"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2021.100818","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2021.100818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2021.102266","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100818"}}